• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

虚拟收集患者报告数据的挑战:在 COVID-19 时代进行的前瞻性队列研究。

Challenges in virtual collection of patient-reported data: a prospective cohort study conducted in COVID-19 era.

机构信息

Department of Surgical Oncology, Princess Margaret Hospital, University Health Network, Toronto, Canada.

Division of General Surgery, Mount Sinai Hospital, Sinai Health System, Toronto, Canada.

出版信息

Support Care Cancer. 2022 Sep;30(9):7535-7544. doi: 10.1007/s00520-022-07191-3. Epub 2022 Jun 7.

DOI:10.1007/s00520-022-07191-3
PMID:35670865
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9171486/
Abstract

UNLABELLED

Prior to the COVID-19 pandemic, patients attending ambulatory clinics at cancer centers in Ontario completed the Edmonton Symptom Assessment Scale (ESAS) at each visit. At our center, completion was via touchpad, with assistance from clinic volunteers. As of March 2020, clinic appointments were conducted virtually when possible and touch pads removed. We anticipated a negative impact on the collection of patient-reported outcomes (PROs) and the recognition of severe symptoms.

METHODS

We performed a prospective cross-sectional cohort study to investigate remote ESAS completion by patients with appointments at a weekly surgical oncology clinic. Patients in the initial study cohort were asked to complete and return the ESAS virtually (V). Given low completion rates, the ensuing cohort was asked to complete a hard-copy (HC) ESAS. For the final cohort, we provided remote, personal mentorship by a member of the care team to support virtual electronic ESAS completion (virtual-mentored (VM) cohort).

RESULTS

Between May and July 2020, a total of 174 patient encounters were included in the study. For the V cohort, 20/46 patients (44%) successfully completed and returned the electronic ESAS, compared to 49/50 (98%) for the HC cohort. For the VM cohort, the overall completion rate was 74% (58/78); however, 12 of these 58 patients did not independently complete a virtual ESAS. Virtual questionnaire completion was not predicted by age, sex, or tumor site, although patients who completed the ESAS were more likely to be in active management rather than surveillance (p = 0.04). Of all completed forms, 42% revealed a depression score of ≥2, and 27% an anxiety score of ≥4.

CONCLUSIONS

We identified significant barriers to the virtual completion of ESAS forms, with a lack of predictive variables. The severe degree of psychological distress reported by ~50% of respondents demonstrates the need for ongoing regular collection/review of these data. Innovative solutions are required to overcome barriers to the virtual collection of PROs.

摘要

目的

在 COVID-19 大流行之前,安大略省癌症中心的门诊患者每次就诊时都会使用埃德蒙顿症状评估量表(ESAS)进行评估。在我们中心,通过触摸板完成评估,由诊所志愿者提供帮助。自 2020 年 3 月以来,只要可能,就通过虚拟方式进行门诊预约,并移除触摸板。我们预计这将对患者报告的结果(PRO)的收集和严重症状的识别产生负面影响。

方法

我们进行了一项前瞻性的横断面队列研究,以调查每周进行一次外科肿瘤学门诊预约的患者的远程 ESAS 完成情况。最初的研究队列中的患者被要求远程填写并返回 ESAS(V 组)。由于完成率较低,随后的队列被要求填写纸质版 ESAS(HC 组)。对于最后一个队列,我们由护理团队的一名成员提供远程个人指导,以支持虚拟电子 ESAS 完成(虚拟指导(VM)组)。

结果

2020 年 5 月至 7 月期间,共有 174 例患者的就诊情况纳入研究。V 组中,有 20/46 名患者(44%)成功完成并返回了电子 ESAS,而 HC 组中这一比例为 49/50 名患者(98%)。VM 组的总体完成率为 74%(58/78);然而,在这 58 名患者中,有 12 名并非独立完成虚拟 ESAS。尽管完成 ESAS 的患者更可能处于积极管理而非监测状态(p=0.04),但年龄、性别或肿瘤部位并不能预测虚拟问卷的完成情况。所有完成的表格中,有 42%的患者抑郁评分≥2,27%的患者焦虑评分≥4。

结论

我们发现虚拟完成 ESAS 表格存在显著障碍,且无预测变量。约 50%的受访者报告存在严重程度的心理困扰,这表明需要持续定期收集/审查这些数据。需要创新解决方案来克服虚拟收集 PRO 的障碍。

相似文献

1
Challenges in virtual collection of patient-reported data: a prospective cohort study conducted in COVID-19 era.虚拟收集患者报告数据的挑战:在 COVID-19 时代进行的前瞻性队列研究。
Support Care Cancer. 2022 Sep;30(9):7535-7544. doi: 10.1007/s00520-022-07191-3. Epub 2022 Jun 7.
2
Province-Wide Analysis of Patient-Reported Outcomes for Stage IV Non-Small Cell Lung Cancer.全省范围内的 IV 期非小细胞肺癌患者报告结局分析。
Oncologist. 2021 Oct;26(10):e1800-e1811. doi: 10.1002/onco.13890. Epub 2021 Jul 17.
3
The impact of automated screening with Edmonton Symptom Assessment System (ESAS) on health-related quality of life, supportive care needs, and patient satisfaction with care in 268 ambulatory cancer patients.埃德蒙顿症状评估系统(ESAS)自动化筛查对 268 例门诊癌症患者的健康相关生活质量、支持性护理需求以及患者对护理满意度的影响。
Support Care Cancer. 2019 Jan;27(1):209-218. doi: 10.1007/s00520-018-4304-0. Epub 2018 Jun 21.
4
Congruence of multiple patient-related outcomes within a single day.同一天内多个患者相关结局的一致性。
Support Care Cancer. 2019 Mar;27(3):867-872. doi: 10.1007/s00520-018-4372-1. Epub 2018 Aug 1.
5
Improving the use of patient-reported outcomes among patients receiving radiation therapy during the COVID-19 pandemic.改善 COVID-19 大流行期间接受放射治疗患者的患者报告结局的应用。
J Med Imaging Radiat Sci. 2022 Sep;53(3):328-333. doi: 10.1016/j.jmir.2022.05.007. Epub 2022 May 25.
6
Testing a modified electronic version of the Edmonton symptom assessment system-revised for remote online completion with ambulatory cancer patients in Alberta, Canada.对埃德蒙顿症状评估系统的一个修改后的电子版进行测试,该版本经过修订以便加拿大艾伯塔省的门诊癌症患者能够远程在线完成评估。
Digit Health. 2023 Jul 27;9:20552076231190998. doi: 10.1177/20552076231190998. eCollection 2023 Jan-Dec.
7
Frequency of anxiety and depression and screening performance of the Edmonton Symptom Assessment Scale in a psycho-oncology clinic.焦虑和抑郁的频率以及心理肿瘤学诊所中 Edmonton 症状评估量表的筛查性能。
Psychooncology. 2022 Feb;31(2):290-297. doi: 10.1002/pon.5813. Epub 2021 Sep 22.
8
Oncology Nurses' Attitudes Toward the Edmonton Symptom Assessment System: Results From a Large Cancer Care Ontario Study.肿瘤护理人员对埃德蒙顿症状评估系统的态度:安大略省大型癌症护理研究的结果。
Oncol Nurs Forum. 2017 Jan 1;44(1):116-125. doi: 10.1188/17.ONF.116-125.
9
Association of Patient-Reported Outcomes With Subsequent Nonfatal Self-injury After a New Cancer Diagnosis.患者报告结局与新发癌症诊断后非致命性自伤的相关性。
JAMA Oncol. 2022 May 1;8(5):e220203. doi: 10.1001/jamaoncol.2022.0203. Epub 2022 May 19.
10
The impact of routine Edmonton Symptom Assessment System (ESAS) use on overall survival in cancer patients: Results of a population-based retrospective matched cohort analysis.常规使用埃德蒙顿症状评估系统(ESAS)对癌症患者总生存的影响:基于人群的回顾性匹配队列分析结果。
Cancer Med. 2020 Oct;9(19):7107-7115. doi: 10.1002/cam4.3374. Epub 2020 Aug 14.

引用本文的文献

1
Pain and Interventions in Stage IV Non-Small Cell Lung Cancer: A Province-Wide Analysis.四期非小细胞肺癌的疼痛与干预:全省范围分析。
Curr Oncol. 2023 Mar 18;30(3):3461-3472. doi: 10.3390/curroncol30030262.

本文引用的文献

1
Online monitoring of patient self-reported adverse events in early phase clinical trials: Views from patients, clinicians, and trial staff.在线监测早期临床试验中患者自报告的不良事件:来自患者、临床医生和试验人员的观点。
Clin Trials. 2021 Apr;18(2):168-179. doi: 10.1177/1740774520972125. Epub 2020 Nov 24.
2
Population-level evidence of survival benefits of patient-reported outcome symptom monitoring software systems in routine cancer care.患者报告结局症状监测软件系统在常规癌症护理中生存获益的人群水平证据。
Cancer Med. 2020 Nov;9(21):7797-7799. doi: 10.1002/cam4.3480. Epub 2020 Oct 7.
3
The impact of routine Edmonton Symptom Assessment System (ESAS) use on overall survival in cancer patients: Results of a population-based retrospective matched cohort analysis.
常规使用埃德蒙顿症状评估系统(ESAS)对癌症患者总生存的影响:基于人群的回顾性匹配队列分析结果。
Cancer Med. 2020 Oct;9(19):7107-7115. doi: 10.1002/cam4.3374. Epub 2020 Aug 14.
4
Patient-reported Outcomes of Patients With Breast Cancer During the COVID-19 Outbreak in the Epicenter of China: A Cross-sectional Survey Study.中国疫情震中地区乳腺癌患者在 COVID-19 大流行期间的患者报告结局:一项横断面调查研究。
Clin Breast Cancer. 2020 Oct;20(5):e651-e662. doi: 10.1016/j.clbc.2020.06.003. Epub 2020 Jun 7.
5
Effect of Cancer on Clinical Outcomes of Patients With COVID-19: A Meta-Analysis of Patient Data.癌症对COVID-19患者临床结局的影响:患者数据的荟萃分析
JCO Glob Oncol. 2020 Jun;6:799-808. doi: 10.1200/GO.20.00225.
6
Psychological Distress and Loneliness Reported by US Adults in 2018 and April 2020.2018 年和 2020 年 4 月美国成年人报告的心理困扰和孤独感。
JAMA. 2020 Jul 7;324(1):93-94. doi: 10.1001/jama.2020.9740.
7
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.COVID-19 对癌症患者的临床影响(CCC19):一项队列研究。
Lancet. 2020 Jun 20;395(10241):1907-1918. doi: 10.1016/S0140-6736(20)31187-9. Epub 2020 May 28.
8
Evidence mounts on the disproportionate effect of COVID-19 on ethnic minorities.越来越多的证据表明,新冠病毒病对少数族裔产生了不成比例的影响。
Lancet Respir Med. 2020 Jun;8(6):547-548. doi: 10.1016/S2213-2600(20)30228-9. Epub 2020 May 10.
9
COVID-19 and Racial/Ethnic Disparities.新冠病毒病与种族/民族差异
JAMA. 2020 Jun 23;323(24):2466-2467. doi: 10.1001/jama.2020.8598.
10
Variation in COVID-19 Hospitalizations and Deaths Across New York City Boroughs.纽约市各行政区的 COVID-19 住院和死亡情况存在差异。
JAMA. 2020 Jun 2;323(21):2192-2195. doi: 10.1001/jama.2020.7197.